The 5mg vial makes more sense for low-dose protocols where the 28-day window is the bottleneck
Yes, some GLP-1 receptor agonists, such as liraglutide and semaglutide, have been shown to reduce the risk of major cardiovascular events in people with type 2 diabetes and cardiovascular disease
In-network with Moda Health, Alaska Medicaid, Cigna, Aetna, or $150 /month membership Avabilable
It can also open productive discussions about ongoing treatment options including continuing semaglutide (injectable), switching to an oral option like Motus (oral), or combining medication with structured lifestyle and coaching supports
Safe and transparent Our master nurse injectors administer FDA-approved treatments under the direct supervision of a medical director
However, it is crucial to note that more studies are needed on this